In this regard, our study demonstrated the expression of CD70 and CD27 in the majority of MCL samples and co-expression in 38% of patients, suggesting that the CD70/CD27 axis is a more attractive target for therapy in case of MCL patients. Here, CD27 is linked to mantle cell lymphoma.